Plasma Fractionation Market: By Product Type, By Application, By End Users and Geography

download arrow download arrow Download Free Sample
settings arrow settings arrow email us

Plasma Fractionation Market Size, Share, Growth, Trends, and Global Industry Analysis: By Product Type (Albumin, Immunoglobulin, Coagulation Factor Concentrates, Protease Inhibitors and Other Plasma Fractionation Products), By Application (Neurology, Haematology, Immunology, Rheumatology, Haemato-oncology, Critical Care, Pulmonology and Others), By End Users (Hospitals, Clinics, Academic Institutes and Clinical Research Laboratories) and Region

checked icon arrow_drop_down
checked icon Single User License $4400 $3520
checked icon Multiple User License $6600 $5280
checked icon Corporate User License $8900 $7120

Plasma Fractionation Market size was valued at US$ 26.8 billion in 2023 and is projected to reach US$ 40.2 billion by 2030, growing at a CAGR of 6.8% from 2024-2030. plasma fractionation is a vital medical process used to separate the components of blood plasma, the liquid part of blood. This process is crucial for producing various blood-derived medical products. It starts with collecting whole blood from donors, which is then spun in a centrifuge to separate its components: red blood cells, white blood cells, platelets, and plasma. Plasma, making up about 55% of blood volume, plasma undergoes fractionation to break it down into key protein components like albumin, immunoglobulins (antibodies), and clotting factors. These components are meticulously purified to meet strict safety and quality standards. Once purified, they can be formulated into medical products such as clotting factor concentrates for hemophilia, immune globulins for immunodeficiency disorders, and albumin for fluid replacement therapy. is the focus.

key drivers fueling the growth of the market are the Increasing demand for plasma-derived therapies to treat various medical conditions, A rising aging population with age-related diseases that require plasma-derived products, Ongoing advancements in medical science expanding the applications of these products, Increased awareness through healthcare campaigns, leading to greater demand. In the market, various segments cater to different medical specialties and applications. These segments include Neurology, Haematology, Immunology, Rheumatology, Haemato-oncology, Critical Care, Pulmonology, and others. Among these, the Neurology segment is anticipated to experience the fastest-growing market during the forecast period from 2023 to 2029. The growth of the Neurology segment suggests an increasing demand for plasma-derived products in the field of neurology, possibly for the treatment of neurological disorders and conditions. This could be due to advancements in therapeutic options and the expanding role of plasma-derived therapies in addressing neurological diseases.

Plasma Fractionation Market Key Developments

  • In Aug 2022, CSL Plasma reimagines donor experience with first donations completed on innovative plasma collection technology.
  • In May 2022, CSL Behring's Biologics License got approval from FDA for Etranacogene Dezaparvovec for Priority Review.  

summary download arrow Download Free Sample

Global Plasma Fractionation Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

6.8%

Largest Market

North America

Fastest Growing Market

Asia Pacific

Plasma Fractionation Market Dynamics

The plasma fractionation market is experiencing significant growth, and several key drivers are fueling this expansion:

  1. Increasing demand for plasma-derived therapies to treat various medical conditions.
  2. A rising aging population with age-related diseases that require plasma-derived products.
  3. Ongoing advancements in medical science expanding the applications of these products.
  4. Increased awareness through healthcare campaigns, leading to greater demand.
  5. Expanding healthcare infrastructure and rising expenditure in emerging markets, 

Global Plasma Fractionation Market Segmentation Analysis

Report Benchmarks

Details

Report Study Period

2024-2030

Market Size in 2023

US$ 26.8 billion

Market Size in 2030

US$ 40.2 billion

Market CAGR

6.8%

By Product Type

  • Albumin
  • Immunoglobulin
  • Coagulation Factor Concentrates
  • Protease Inhibitors
  • Other Plasma Fractionation Products

By Application

  • Neurology
  • Haematology
  • Immunology
  • Rheumatology
  • Haemato-oncology
  • Critical Care
  • Pulmonology
  • Others

By End User

  • Hospitals
  • Clinics
  • Academic Institutes
  • Clinical Research Laboratories

Key Features of the Report

  • The plasma fractionation market report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor's overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
  • The report analyses the impact of the socio-political environment through PESTLE Analysis and competition through Porter's Five Force Analysis in addition to recent technology advancements and innovations in the market

Download Free Sample Report

I accept the Terms and Conditions,Disclaimers, GDPR Policy

Frequently Asked Questions

"The global plasma fractionation market size was valued at US$ 26.8 million in 2023 and is projected to grow at a CAGR of 6.8% from 2024 to 2030.

Rising prevalence of bleeding disorders will create lucrative opportunity in the global market due to major applications of plasma fractionation products.

Collaborations and new product launches and investment in R&D sector are the main strategies of the global players to establish in the market.

Decreasing supply of plasma due to low donor turnout may hamper the global market growth at a significant rate.

Author image

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

1.Executive Summary
2.Global Plasma Fractionation Market Introduction 
2.1.Global Plasma Fractionation Market  - Taxonomy
2.2.Global Plasma Fractionation Market  - Definitions
2.2.1.Product Type
2.2.2.Application
2.2.3.End User
2.2.4.Region
3.Global Plasma Fractionation Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Plasma Fractionation Market Analysis, 2019 - 2023 and Forecast 2024 - 2030
4.1.  Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Plasma Fractionation Market  By Product Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
5.1. Albumin
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Immunoglobulin
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Coagulation Factor Concentrates
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
5.4. Protease Inhibitors
5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.4.3. Market Opportunity Analysis 
5.5. Other Plasma Fractionation Products
5.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.5.3. Market Opportunity Analysis 
6.Global Plasma Fractionation Market  By Application, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
6.1. Neurology
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Haematology
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Immunology
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. Rheumatology
6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
6.5. Haemato-oncology
6.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.5.3. Market Opportunity Analysis 
6.6. Critical Care
6.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.6.3. Market Opportunity Analysis 
6.7. Pulmonology
6.7.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.7.3. Market Opportunity Analysis 
6.8. Others
6.8.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.8.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.8.3. Market Opportunity Analysis 
7.Global Plasma Fractionation Market  By End User, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
7.1. Hospitals
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Clinics
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Academic Institutes
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
7.4. Clinical Research Laboratories
7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.4.3. Market Opportunity Analysis 
8.Global Plasma Fractionation Market  By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
8.1. North America
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Europe
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Asia Pacific (APAC)
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Middle East and Africa (MEA)
8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
8.5. Latin America
8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.5.3. Market Opportunity Analysis 
9.North America Plasma Fractionation Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
9.1. Product Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.Albumin
9.1.2.Immunoglobulin
9.1.3.Coagulation Factor Concentrates
9.1.4.Protease Inhibitors
9.1.5.Other Plasma Fractionation Products
9.2.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Neurology
9.2.2.Haematology
9.2.3.Immunology
9.2.4.Rheumatology
9.2.5.Haemato-oncology
9.2.6.Critical Care
9.2.7.Pulmonology
9.2.8.Others
9.3.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.Hospitals
9.3.2.Clinics
9.3.3.Academic Institutes
9.3.4.Clinical Research Laboratories
9.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.4.1.United States of America (USA)
9.4.2.Canada
10.Europe Plasma Fractionation Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
10.1. Product Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Albumin
10.1.2.Immunoglobulin
10.1.3.Coagulation Factor Concentrates
10.1.4.Protease Inhibitors
10.1.5.Other Plasma Fractionation Products
10.2.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Neurology
10.2.2.Haematology
10.2.3.Immunology
10.2.4.Rheumatology
10.2.5.Haemato-oncology
10.2.6.Critical Care
10.2.7.Pulmonology
10.2.8.Others
10.3.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Hospitals
10.3.2.Clinics
10.3.3.Academic Institutes
10.3.4.Clinical Research Laboratories
10.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Germany
10.4.2.France
10.4.3.Italy
10.4.4.United Kingdom (UK)
10.4.5.Spain
11.Asia Pacific (APAC) Plasma Fractionation Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
11.1. Product Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Albumin
11.1.2.Immunoglobulin
11.1.3.Coagulation Factor Concentrates
11.1.4.Protease Inhibitors
11.1.5.Other Plasma Fractionation Products
11.2.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Neurology
11.2.2.Haematology
11.2.3.Immunology
11.2.4.Rheumatology
11.2.5.Haemato-oncology
11.2.6.Critical Care
11.2.7.Pulmonology
11.2.8.Others
11.3.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Hospitals
11.3.2.Clinics
11.3.3.Academic Institutes
11.3.4.Clinical Research Laboratories
11.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.China
11.4.2.India
11.4.3.Australia and New Zealand (ANZ)
11.4.4.Japan
11.4.5.Rest of APAC
12.Middle East and Africa (MEA) Plasma Fractionation Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
12.1. Product Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Albumin
12.1.2.Immunoglobulin
12.1.3.Coagulation Factor Concentrates
12.1.4.Protease Inhibitors
12.1.5.Other Plasma Fractionation Products
12.2.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Neurology
12.2.2.Haematology
12.2.3.Immunology
12.2.4.Rheumatology
12.2.5.Haemato-oncology
12.2.6.Critical Care
12.2.7.Pulmonology
12.2.8.Others
12.3.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Hospitals
12.3.2.Clinics
12.3.3.Academic Institutes
12.3.4.Clinical Research Laboratories
12.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.GCC Countries
12.4.2.South Africa
12.4.3.Rest of MEA
13.Latin America Plasma Fractionation Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
13.1. Product Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Albumin
13.1.2.Immunoglobulin
13.1.3.Coagulation Factor Concentrates
13.1.4.Protease Inhibitors
13.1.5.Other Plasma Fractionation Products
13.2.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Neurology
13.2.2.Haematology
13.2.3.Immunology
13.2.4.Rheumatology
13.2.5.Haemato-oncology
13.2.6.Critical Care
13.2.7.Pulmonology
13.2.8.Others
13.3.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Hospitals
13.3.2.Clinics
13.3.3.Academic Institutes
13.3.4.Clinical Research Laboratories
13.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Brazil
13.4.2.Mexico
13.4.3.Rest of LA
14. Competition Landscape
14.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
14.2.1.Grifols S.A (Spain)
14.2.2.CSL Ltd. (Australia)
14.2.3.Shire (Ireland
14.2.4.Octapharma AG (Switzerland)
14.2.5.Kedrion S.p.A (Italy)
14.2.6.China Biologic Products, Inc. (China)
14.2.7.Biotest AG (OGEL GmbH) (Germany)
14.2.8.LFB S.A (France)
14.2.9.Sanquin (Netherlands)
15. Research Methodology 
16. Appendix and Abbreviations 

Key Market Players

  • Grifols S.A
  • CSL Ltd.
  • Shire
  • Octapharma AG
  • Kedrion S.p.A
  • China Biologic Products, Inc.
  • Biotest AG (OGEL GmbH)
  • LFB S.A
  • Sanquin

Related Industry Reports

Egypt Diabetes Devices Market

Lithuania Surgical Equipment Market

Antimicrobials Market

Cancer Therapy Market